Study: Patients Report Herbal Cannabis Provides Insomnia Relief

Generic 1 August 2018 | 0 Comments

The use of herbal cannabis is associated with reductions in self-perceived insomnia severity, according to data published in the online, open-access journal Medicines. University of New Mexico researchers assessed the influence of marijuana use on self-perceived insomnia severity levels in 409 subjects. Study participants recorded real-time ratings of their symptom severity on a zero to [...]

Tagged in , ,

FDA Approves Marketing Of Plant-Derived Marijuana Medicine

Generic 25 June 2018 | 0 Comments

Regulators at the US Food and Drug Administration today granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The FDA’s decision was not unexpected, as the proprietary extract formulation — developed by [...]

Tagged in , , ,

Weekly Legislative Roundup 5/4/18

Generic 5 May 2018 | 0 Comments

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! Let’s talk about some new state-level developments. The Maine House of Representatives and Senate overrode Gov. Paul LePage’s (R) veto of marijuana legalization implementation legislation this week. The enactment of the legislation establishes a framework for the retail sale of marijuana to adults, but also amends numerous [...]

Tagged in , , ,

Ninth Circuit Court Rejects Challenge To DEA’s Classification Of Marijuana Extracts

Generic 3 May 2018 | 0 Comments

A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. The DEA first announced the proposed rule change in 2011, but did not enact the new policy until January [...]

Tagged in , , ,

Weekly Legislative Roundup 4/27/18

Generic 28 April 2018 | 0 Comments

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! A lot of action was taken in Congress this week.  A bipartisan coalition of House lawmakers has introduced legislation, the Medical Cannabis Research Act of 2018, to facilitate federally-approved clinical trials involving cannabis. The act ends the University of Mississippi’s existing monopoly on the growth [...]

Tagged in , , ,